Optimal phosphate control in dialysis patients is extremely challenging. A growing awareness of the deleterious effect of mineral metabolism imbalances together with the lack of a satisfactory explanation for the exaggerated mortality rate in patients undergoing renal replacement therapy has led to a renewed effort to refine our approach to hyperphosphatemia. However, despite the remarkable improvements in dialysis techniques, phosphate control has not substantially improved. Achieving normo-phosphatemia presents a multitude of practical and scientific challenges related to the optimal target level, cardiovascular health, and drug toxicities. It is the aim of the present review to summarize briefly the controversies associated with currently available phosphate binders, a cornerstone in the current management of hyperphosphatemia.

Phosphate binders : new products and challenges / A. Bellasi, L. Kooienga, G.A. Block. - In: HEMODIALYSIS INTERNATIONAL. - ISSN 1492-7535. - 10:3(2006 Jul), pp. 225-234.

Phosphate binders : new products and challenges

A. Bellasi
Primo
;
2006-07

Abstract

Optimal phosphate control in dialysis patients is extremely challenging. A growing awareness of the deleterious effect of mineral metabolism imbalances together with the lack of a satisfactory explanation for the exaggerated mortality rate in patients undergoing renal replacement therapy has led to a renewed effort to refine our approach to hyperphosphatemia. However, despite the remarkable improvements in dialysis techniques, phosphate control has not substantially improved. Achieving normo-phosphatemia presents a multitude of practical and scientific challenges related to the optimal target level, cardiovascular health, and drug toxicities. It is the aim of the present review to summarize briefly the controversies associated with currently available phosphate binders, a cornerstone in the current management of hyperphosphatemia.
Calcium salts; lanthanum carbonate; Mixed metal hydroxides; Phosphate binders; Sevelamer hydrochloride; Vascular calcification
Settore MED/14 - Nefrologia
Article (author)
File in questo prodotto:
File Dimensione Formato  
Bellasi Hemodyalisi International 2006.PDF

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 126.3 kB
Formato Adobe PDF
126.3 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/256175
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 41
  • ???jsp.display-item.citation.isi??? ND
social impact